Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.
Clinical trial NCT02919059 · UNKNOWN
Trial details
- NCT number
- NCT02919059
- Sponsor
- IInstituto Gallego de Medicina Vascular
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-13
- Primary completion
- 2018-12-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.